Search
-
Department of Psychiatry & Behavioral Sciences
A continually updated listing of the Department of Psychiatry & Behavioral Sciences' current clinical trials.
… A listing of our available clinical trials:
-
News
Learn how proton therapy can be an effective new treatment for leptomeningeal metastasis.
… Monday, June 6, 2022 Leptomeningeal metastasis (LM) is a serious condition in which cancer spreads to the fluid and tissues surrounding the brain and spinal cord. This complication can have devastating effects, causing pain, seizures, difficulty thinking, and a loss of muscle control. Treatment with
-
News
In honor of Women's History Month, meet the scientific hero who shook up cancer research with her unusual findings.
… Wednesday, March 13, 2019 Summary In honor of Women’s History Month, we’re remembering female scientists from MSK’s past who shook up cancer research. Read about Ora Rosen and Mathilde Krim . In the 1950s, the idea that cancer might be caused by a virus was somewhat heretical. Most known viruses caused
-
The Training Program in Laboratory Animal Medicine and Science is dedicated to providing qualified veterinarians with the knowledge and technical skills necessary to develop a successful career in laboratory animal medicine and science in an academic or industrial setting.
… The Tri-Institutional Training Program in Laboratory Animal Medicine and Science is dedicated to providing qualified veterinarians with the knowledge and technical skills necessary to develop a successful career in laboratory animal medicine and science in academia, government, or industry. The program
-
Event
… Cycle for Survival is the official rare cancer fundraising program of Memorial Sloan Kettering Cancer Center (MSK), which means that 100% of every dollar raised goes directly to research at MSK. Join us to ride stationary bikes and accelerate progress for people with rare cancer around the world. How
-
Myeloma SpecialistI am a medical oncologist with special training in the care of people with multiple myeloma and other plasma cell disorders, including monoclonal gammopathy of undetermined significance (MGUS), smoldering multiple myeloma, and amyloidosis. I see patients at Memorial Sloan Kettering Bergen in New Jersey. I aim to understand each patient on a personal level and tailor care to their specific diagnosis and needs.
… Myeloma Specialist Job Title Assistant Attending Physician I am a medical oncologist with special training in the care of people with multiple myeloma and other plasma cell disorders , including monoclonal gammopathy of undetermined significance (MGUS) , smoldering multiple myeloma , and amyloidosis
-
Myeloma SpecialistSoy oncólogo médico y tengo formación especializada en la atención de personas con mieloma múltiple y otros trastornos de las células plasmáticas que incluyen gammapatía monoclonal de significado incierto (MGUS), mieloma múltiple latente y amiloidosis. Atiendo pacientes en Memorial Sloan Kettering Bergen en Nueva Jersey. Mi objetivo es entender a cada paciente a un nivel personal y diseñar la atención según su diagnóstico y sus necesidades específicas.
… Myeloma Specialist Job Title Médico adjunto asistente Soy oncólogo médico y tengo formación especializada en la atención de personas con mieloma múltiple y otros trastornos de las células plasmáticas que incluyen gammapatía monoclonal de significado incierto (MGUS) , mieloma múltiple latente y amiloidosis
-
… Job Title Clinical Research Coordinator
-
MSK News
In cancer care, firsts make a difference. At MSK, we are constantly improving how we help people with those important firsts. Dr. Selwyn Vickers writes about the latest developments at MSK and the encouraging evidence that we are making progress in our mission of ending cancer for life.
… Saturday, July 1, 2023 Dear MSK Community, In cancer care, firsts make a difference: The first tests that diagnosis the disease. The first choices about where to be treated. The first decisions about how to treat it. At Memorial Sloan Kettering Cancer Center (MSK), we are constantly improving how we
-
News
More than 30,000 oncology professionals from around the world will gather in Chicago from May 31 to June 4 for the 2019 American Society of Clinical Oncology (ASCO) Annual Meeting. For more information and to set up interviews, email [email protected]. Follow the meeting live on Twitter using the hashtag #ASCO19 and follow MSK on Twitter at @sloan_kettering.
… Wednesday, May 29, 2019 More than 30,000 oncology professionals from around the world will gather in Chicago from May 31 to June 4 for the 2019 American Society of Clinical Oncology (ASCO) Annual Meeting. MSK scientists and physicians will take part in nearly 140 presentations from plenary sessions to